C
Eli Lilly and Company LLY
$1,059.70 $16.411.57% NYSE
Recommendation
Prev Close
$1,059.70
Volume
4,266,704
Avg Vol (90D)
4,454,263
Market Cap
$948.84B
Dividend & Yield
$6.00(0.57%)
52-Week Range
$623.78 - $1,066.65
P/E (TTM)
51.84
EPS (TTM)
$20.44
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
A Magnificent AI Bet? Stanley Druckenmiller’s Latest Tech Moves
11/21/2025 - MarketBeat
Top Pharmaceutical Stocks To Keep An Eye On - November 22nd
11/22/2025 - MarketBeat
Medical Stocks To Watch Now - November 22nd
11/22/2025 - MarketBeat
Eli Lilly Stock (LLY) Achieves $1 Trillion Market Cap
11/22/2025 - TipRanks Financial Blog
Ford, Coca-Cola, GE, Eli Lilly, Energy Transfer: Insider Moves Unveiled!
11/22/2025 - TipRanks Financial Blog
Rhumbline Advisers Has $1.14 Billion Stake in Eli Lilly and Company $LLY
11/22/2025 - MarketBeat
Dow Jones Futures: Stocks Bounce, Still Battered; Nvidia, Apple, Eli Lilly In Focus
11/22/2025 - Yahoo! Finance: News
Eli Lilly and Company $LLY Shares Purchased by Hillsdale Investment Management Inc.
11/22/2025 - MarketBeat
Eli Lilly: The Weight-Loss Leader With More Upside If Execution Holds
11/22/2025 - Seeking Alpha - Long Ideas
Eli Lilly: The Weight-Loss Leader With More Upside If Execution Holds
11/22/2025 - SeekingAlpha
Cowa LLC Buys Shares of 282 Eli Lilly and Company $LLY
11/22/2025 - MarketBeat
Cozad Asset Management Inc. Purchases 1,629 Shares of Eli Lilly and Company $LLY
11/22/2025 - MarketBeat
CenterBook Partners LP Makes New $26.77 Million Investment in Eli Lilly and Company $LLY
11/22/2025 - MarketBeat
Cooper Haims Advisors LLC Purchases Shares of 330 Eli Lilly and Company $LLY
11/22/2025 - MarketBeat
When Investors Panic, I Buy Eli Lilly
11/22/2025 - SeekingAlpha
When Investors Panic, I Buy Eli Lilly
11/22/2025 - Seeking Alpha - Long Ideas
Eli Lilly and Company $LLY Position Boosted by AlphaCore Capital LLC
11/22/2025 - MarketBeat
Eli Lilly and Company (NYSE:LLY) Receives Consensus Recommendation of "Moderate Buy" from Analysts
11/22/2025 - MarketBeat
Is There Still Value in Lilly After a 36% Jump and Analyst Upgrades in 2025?
11/22/2025 - Simply Wall St
Eli Lilly and Company (LLY) Welcomes New Board Member
11/22/2025 - GuruFocus
Eli Lilly and Company (NYSE:LLY) Trading 1.4% Higher - Here's Why
11/21/2025 - MarketBeat
LLY Becomes Biggest Healthcare Company: Analyzing Stock's Stunning Rally
11/21/2025 - Schwab Network
Mounjaro maker Eli Lilly swells to $1trillion
11/21/2025 - Money Mail Online
Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Value
11/21/2025 - New York Times - Business
HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?
11/19/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$59.42B
EBITDA (TTM)
$28.73B
EBIT (TTM)
$26.83B
Net Income (TTM)
$18.41B
Balance Sheet
Total Assets (Q)
$114.94B
Total Debt (Q)
$42.58B
Total Liabilities (Q)
$91.08B
Book Value Per Share (Q)
$26.56
Cash Flow
Cash from Operations (TTM)
$16.06B
Cash from Investing (TTM)
-$10.09B
Cash from Financing (TTM)
$440.40M
Net Change in Cash (TTM)
$6.42B
Filings
Filing Date
Thursday, October 30, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 16 and 20 (est)
Price History
Loading...
Beta
0.77
7-Day Total Return
3.76%
30-Day Total Return
29.52%
60-Day Total Return
44.87%
90-Day Total Return
37.83%
Year to Date Total Return
37.21%
1-Year Total Return
42.73%
2-Year Total Return
80.57%
3-Year Total Return
200.71%
5-Year Total Return
678.80%
52-week Low
Aug 08, 2025 - $623.78
52-week High
Nov 21, 2025 - $1,066.65
Valuation
Market Cap
$948.84B - Mega Cap
Enterprise Value
$981.24B
Price/Sales (TTM)
16.03
Price/Book (Q)
39.90
Dividends and Shares
Shares Outstanding
898.80
Dividend Per Share (Most Recent)
$1.50
Dividend Per Share (TTM)
$6.00
Corporate Info
Website
www.lilly.com
Phone Number
317 276 2000
Address
Lilly Corporate Center
Indianapolis, IN 46285
Country
United States
Year Founded
1876
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix... more
NYSE 11/21/2025 4:00PM Eastern Quotes delayed